![Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma - ScienceDirect Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405471220302490-fx1.jpg)
Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma - ScienceDirect
![Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols - ScienceDirect Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2667031322000458-ga1.jpg)
Hepatocellular carcinoma and miRNAs: An in silico approach revealing potential therapeutic targets for polyphenols - ScienceDirect
![Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework | Science Advances Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework | Science Advances](https://www.science.org/cms/10.1126/sciadv.abn9828/asset/1b07d3b6-da05-4388-8a75-7636ee181cbd/assets/images/large/sciadv.abn9828-f2.jpg)